Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 460
Immune Disorders Drugs 195
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 116
Endocrine and Metabolic Disorders Drugs 103
Central Nervous System Drugs 102
Drug Discovery 101
Musculoskeletal Disorders Drugs 92
Pharmaceuticals 89
Clinical Trials 89
Hematological Drugs 83
Leukemia Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 63
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 49
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 25
Bladder Cancer Drugs 24
Drugs by Therapeutic Area 23
Antibiotics 23
Kidney Cancer Drugs 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Uterine Cancer Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

2,372 Results (Page 10 of 119)
- Relevance
  Sort by

Glioblastoma Multiforme Treatment Market Report by Drug Type, Route of Administration, Type of Molecule, Distribution Channel, and Region 2026-2034

 Report
May 2026
137 Pages
Global

From

€3687EUR$3,999USD£3,124GBP

Glioblastoma Multiforme Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
August 2026
120 Pages
Global

From

€4379EUR$4,750USD£3,711GBP

Gardner Syndrome Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4139EUR$4,490USD£3,508GBP

Bladder Cancer Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
July 2025
210 Pages
Global

From

€4605EUR$4,995USD£3,902GBP

Adult Malignant Glioma Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
July 2026
120 Pages
Global

From

€4379EUR$4,750USD£3,711GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Brain Tumor Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
July 2026
114 Pages
Global

From

€4379EUR$4,750USD£3,711GBP

Anaplastic Thyroid Cancer Drugs Market - Global Strategic Business Report

 Report
October 2026
142 Pages
Global

From

€5393EUR$5,850USD£4,570GBP

Follicular Thyroid Cancer Drugs Market - Global Strategic Business Report

 Report
October 2026
278 Pages
Global

From

€5393EUR$5,850USD£4,570GBP

Colorectal Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4139EUR$4,490USD£3,508GBP

Schizophrenia Drugs Market Report by Treatment, Therapeutic Class, Distribution Channel, Country and Company Analysis 2026-2034

 Report
June 2026
200 Pages
Global

From

€2756EUR$2,990USD£2,336GBP

Schizophrenia Therapeutics Market - Global Forecast 2026-2032

 Report
September 2026
184 Pages
Global

From

€3268EUR$3,545USD£2,769GBP

€3631EUR$3,939USD£3,077GBP

Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report

 Report
October 2026
253 Pages
Global

From

€5393EUR$5,850USD£4,570GBP

Schizophrenia Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
July 2026
143 Pages
Global

From

€4379EUR$4,750USD£3,711GBP

Metastatic Colorectal Cancer - Pipeline Insight, 2025

 Drug Pipelines
April 2025
280 Pages
Global

From

€2766EUR$3,000USD£2,344GBP

Brain & Spinal Cord Cancer Market - Global Forecast 2026-2032

 Report
January 2026
188 Pages
Global

From

€3268EUR$3,545USD£2,769GBP

€3631EUR$3,939USD£3,077GBP

Glioma Treatment Market - Global Forecast 2026-2032

 Report
January 2026
197 Pages
Global

From

€3268EUR$3,545USD£2,769GBP

€3631EUR$3,939USD£3,077GBP

Melanoma Therapeutics: Global Markets

 Report
November 2023
131 Pages
Global

From

€4287EUR$4,650USD£3,632GBP

Cephalosporin Drugs - Global Strategic Business Report

 Report
October 2026
398 Pages
Global

From

€5393EUR$5,850USD£4,570GBP

Antimicrobial Therapeutics Market - Global Strategic Business Report

 Report
October 2026
494 Pages
Global

From

€5393EUR$5,850USD£4,570GBP

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2026

 Report
September 2026
550 Pages
Global

From

€4605EUR$4,995USD£3,902GBP

2,372 Results (Page 10 of 119)
- 1
- 8
- 9
- 10
- 11
- 12

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.